ARTICLES BY THIS AUTHOR
- 2/23/2009
New breast cancer indication for Avastin
Hoffmann-La Roche's Avastin (bevacizumab for injection) is now indicated for use in combination with paclitaxel for the treatment of patients with metastatic HER2-negative breast cancer who are ECOG (Eastern Cooperative Oncology Group) Class 0-1.